Cargando…
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity
Non-alcoholic fatty liver disease (NAFLD) is a heterogeneous condition with a wide spectrum of clinical presentations and natural history and disease severity. There is also substantial inter-individual variation and variable response to a different therapy. This heterogeneity of NAFLD is in turn in...
Autores principales: | Pal, Partha, Palui, Rajan, Ray, Sayantan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637673/ https://www.ncbi.nlm.nih.gov/pubmed/34904031 http://dx.doi.org/10.4254/wjh.v13.i11.1584 |
Ejemplares similares
-
Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus
por: Palui, Rajan, et al.
Publicado: (2021) -
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
por: Raj, Henith, et al.
Publicado: (2019) -
Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology
por: Zhao, Jiahui, et al.
Publicado: (2023) -
The microbiome in non-alcoholic fatty liver disease: associations and implications
por: Lin, Eugenia A., et al.
Publicado: (2014) -
Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
por: Santacroce, Giovanni, et al.
Publicado: (2023)